journal article·2018-12-26

Beyond the Roles in Biomimetic Chemistry: An Insight into the Intrinsic Catalytic Activity of an Enzyme for Tumor-Selective Phototheranostics

Weitao Yang, Xiudong Shi, Yuxin Shi, Defan Yao, Shizhen Chen, Xin Zhou, Bingbo Zhang

ACS Nano· Volume 12· Issue 12
Publisher page

Abstract

Protein-assisted biomimetic synthesis has been an emerging offshoot of nanofabrication in recent years owing to its features of green chemistry, facile process, and ease of multi-integration. As a result, many proteins have been used for biomimetic synthesis of varying kinds of nanostructures. Although the efforts on exploring new proteins and investigating their roles in biomimetic chemistry are increasing, the most essential intrinsic properties of proteins are largely neglected. Herein we report a frequently used enzyme (horseradish peroxidase, HRP) to demonstrate the possibility of enzymatic activity retaining after accomplishing the roles in biomimetic synthesis of ultrasmall gadolinium (Gd) nanodots and stowing its substrate 2,2′-Azinobis (3-ethylbenzothiazoline-6-sulfonic acid ammonium salt) (ABTS), denoted as Gd@HRPABTS. It was found that ca. 70% of the enzymatic activity of HRP was preserved. The associated changes of protein structure with chemical treatments were studied by spectroscopic analysis. Leveraging on the highly retained catalytic activity, Gd@HRPABTS exerts strong catalytic oxidation of peroxidase substrate ABTS into photoactive counterparts in the presence of intrinsic H2O2 inside the tumor, therefore enabling tumor-selective catalytic photoacoustic (PA) imaging and photothermal therapy (PTT). In addition, the MR moiety of Gd@HRPABTS provides guidance for PTT and further diagrams that Gd@HRPABTS is clearable from the body via kidneys. Preliminary toxicity studies show no observed adverse effects by administration of them. This study demonstrates beyond the well-known roles in biomimetic chemistry that HRP can also preserve its enzymatic activity for tumor catalytic theranostics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Photomedicine, Shanghai Skin Disease Hospital, The Institute for Biomedical Engineering and Nano Science, Tongji University School of Medicine, Shanghai 200443, China

Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China

Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences, Wuhan 430071, China

Funding

Ministry of Education of the People's Republic of China · China Postdoctoral Science Foundation · National Natural Science Foundation of China · Shanghai Skin Disease Hospital · State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics

References (40)

Show source-provided references
1. 10.1021/acsnano.6b0786610.1021/acsnano.6b07866 ↗
2. 10.1021/ja806804u10.1021/ja806804u ↗
3. 10.1021/acsnano.6b0576010.1021/acsnano.6b05760 ↗
4. 10.1039/C6TB02308H10.1039/C6TB02308H ↗
5. 10.7150/thno.1936510.7150/thno.19365 ↗
6. 10.1002/adma.20160502110.1002/adma.201605021 ↗
7. 10.1021/nn507130k10.1021/nn507130k ↗
8. 10.1016/j.biomaterials.2018.01.05010.1016/j.biomaterials.2018.01.050 ↗
9. 10.1002/adma.20170114610.1002/adma.201701146 ↗
10. 10.1021/acsnano.7b0423010.1021/acsnano.7b04230 ↗
11. 10.1002/adma.20160190210.1002/adma.201601902 ↗
12. 10.1002/adfm.20160134110.1002/adfm.201601341 ↗
13. 10.1002/adma.20150611910.1002/adma.201506119 ↗
14. 10.1002/smll.20170252910.1002/smll.201702529 ↗
15. 10.1002/ange.20171255010.1002/ange.201712550 ↗
16. 10.1021/acsnano.7b0861610.1021/acsnano.7b08616 ↗
17. 10.1021/acsnano.7b0350710.1021/acsnano.7b03507 ↗
18. 10.1038/nbt.398710.1038/nbt.3987 ↗
19. 10.1021/acs.accounts.8b0024210.1021/acs.accounts.8b00242 ↗
20. 10.1039/C6TB02308H10.1039/C6TB02308H ↗
21. 10.2174/092986732466617031414333510.2174/0929867324666170314143335 ↗
22. 10.1039/c2jm30629h10.1039/c2jm30629h ↗
23. 10.1103/PhysRevB.55.143010.1103/PhysRevB.55.1430 ↗
24. 10.1016/j.jcis.2010.11.01210.1016/j.jcis.2010.11.012 ↗
25. 10.1016/j.jcis.2005.02.08910.1016/j.jcis.2005.02.089 ↗
26. 10.1021/acsnano.6b0795910.1021/acsnano.6b07959 ↗
27. 10.1002/adma.20150338110.1002/adma.201503381 ↗
28. 10.1002/anie.20080021210.1002/anie.200800212 ↗
29. 10.1039/C5CC00285K10.1039/C5CC00285K ↗
30. 10.1021/cr980440x10.1021/cr980440x ↗
31. 10.1016/S1381-1177(02)00057-710.1016/S1381-1177(02)00057-7 ↗
32. 10.1073/pnas.170197611410.1073/pnas.1701976114 ↗
33. 10.1186/1556-276X-8-17010.1186/1556-276X-8-170 ↗
34. 10.1002/anie.20151003110.1002/anie.201510031 ↗
35. 10.1002/adma.20170168310.1002/adma.201701683 ↗
36. 10.1002/adma.20170037310.1002/adma.201700373 ↗
37. 10.1002/adma.20160668110.1002/adma.201606681 ↗
38. 10.1002/advs.20150022310.1002/advs.201500223 ↗
39. 10.1002/anie.20171170510.1002/anie.201711705 ↗
40. 10.1038/nnano.2017.17010.1038/nnano.2017.170 ↗